Zimmer Biomet Holdings, Inc.
ZBH
$93.24
$0.650.70%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -21.98% | -25.68% | -17.41% | -5.24% | -11.74% |
| Total Depreciation and Amortization | 9.79% | 10.22% | 7.93% | 5.59% | 4.69% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -94.33% | 456.00% | 3,483.33% | 635.48% | 2,504.76% |
| Change in Net Operating Assets | 76.97% | 51.51% | 44.63% | 25.73% | -14.94% |
| Cash from Operations | 13.19% | 6.61% | 9.16% | 10.14% | -5.20% |
| Capital Expenditure | -18.22% | 0.64% | 22.27% | 32.62% | 26.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -404.23% | -535.04% | -752.28% | -138.19% | -104.82% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 65.71% | 32.22% | 33.22% | -13.66% | -307.04% |
| Cash from Investing | -122.46% | -137.85% | -133.76% | 3.08% | -14.02% |
| Total Debt Issued | 73.51% | 169.08% | 600.17% | 765.59% | 187.37% |
| Total Debt Repaid | -62.56% | -382.54% | -442.46% | -442.46% | -102.16% |
| Issuance of Common Stock | -51.64% | -61.84% | -64.85% | -65.10% | -18.79% |
| Repurchase of Common Stock | 43.89% | 74.36% | -48.49% | -82.87% | -25.40% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 2.91% | 3.73% | 3.31% | 2.80% | 2.44% |
| Other Financing Activities | -68.38% | -94.82% | -139.93% | -196.80% | -49.04% |
| Cash from Financing | 167.29% | 298.34% | 167.31% | 123.23% | 36.54% |
| Foreign Exchange rate Adjustments | 211.11% | -98.81% | 359.62% | 42.86% | -2,000.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -39.47% | 161.32% | 36.16% | 1,478.82% | 173.57% |